| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 |
| filingDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb078663ff270c44a5bd5d62c3378e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ff5cd87c435f3628388fcda8634f8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8777cdeef670740e6cc68d2a4fb522a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c7796a47d8198031e9330aaf995665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f387c79a0591081cc4e597fb59abddcd |
| publicationDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017221272-A1 |
| titleOfInvention |
Process for the preparation of idelalisib |
| abstract |
The present invention relates to a process for the preparation of idelalisib or a pharmaceutically acceptable salt thereof, via a novel intermediate namely, 2-fluoro-6-[[(2S)- 2-[[9-(methoxymethyl)purin-6-yl]amino]butanoyl]amino]- N -phenyl-benzamide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023018636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109503430-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109503430-A |
| priorityDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |